This study analyzed modeled prevalence estimates from the NCD Risk Factor Collaboration (NCD‑RisC) across 16 Middle East and North Africa (MENA) countries: Bahrain, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Qatar, Saudi Arabia, Syria, Tunisia, United Arab Emirates, and Yemen. The analysis focused on adults aged 20–29 and 30–39 years, stratified by sex. Risk factors examined were obesity and diabetes (estimates through 2022), hypertension (available through 2019 for ages 30–39 only), and non‑HDL cholesterol (through 2018). Five‑year age bands were aggregated into the two target age groups using equal‑weighted means, with a UN World Population Prospects 2024 population‑weighted aggregation used for sensitivity testing.
Each country × sex × age‑band × risk‑factor time series was assessed using three complementary approaches. First, joinpoint regression yielded average annual percent changes (AAPC) for 1990 to the available endpoint. Second, posterior probabilities of true 1990‑to‑endpoint change were derived from published credible intervals in the NCD‑RisC outputs. Third, a mixed‑effects model tested a year × region (MENA vs rest‑of‑world [ROW]) interaction while allowing country‑level random slopes, enabling direct comparison of regional trajectories against global patterns. Sensitivity analyses excluded conflict‑affected states and Iran to evaluate robustness; correction for multiple testing was applied where appropriate.
The analyses identified a clear sex‑asymmetric divergence between MENA and ROW in cardiometabolic risk trends. In men, MENA worsened more rapidly than ROW for several measures: obesity in ages 20–29 showed an AAPC of +3.49% per year (p=0.009) and in ages 30–39 an AAPC of +2.65% per year (p=0.043). Diabetes in men aged 30–39 increased faster in MENA than ROW (AAPC +1.90%/year; p=0.014). These findings indicate accelerating adiposity and glycemic disorder prevalence among young men in the region.
In contrast, women in MENA showed faster improvement compared with ROW in selected risk factors: hypertension in ages 30–39 declined with an AAPC of −0.58% per year (p=0.001), and non‑HDL cholesterol decreased faster in both age groups (20–29 and 30–39) with p=0.017 for each comparison. Thus, in young women key vascular risk markers related to blood pressure and lipids moved favorably relative to global trends.
Five of the six regionally divergent findings remained statistically significant after correction for multiple testing, supporting the robustness of the sex‑asymmetric pattern.
Country‑level posterior probability analyses reinforced regional patterns. Nearly all country × sex × age cells for obesity showed very probable increases since 1990: 60 of 64 cells indicated a very probable rise. For non‑HDL cholesterol, 52 of 64 cells (81%) demonstrated a probable or very probable decrease since 1990. These posterior patterns point to a pervasive regional increase in overweight and obesity alongside generally improving lipid profiles in many settings.
The authors conducted sensitivity checks including exclusion of conflict‑affected states and Iran, and assessed UN population‑weighted aggregation versus equal weighting. The mixed‑effects model comparing MENA with ROW incorporated country‑level random slopes to account for between‑country heterogeneity. The majority of divergent regional findings survived correction for multiple testing and remained consistent across sensitivity analyses reported in the source.
The observed sex‑asymmetric divergence—accelerating obesity and diabetes among young men in MENA versus improving hypertension and non‑HDL cholesterol among young women—maps directly onto the young‑male acute myocardial infarction (AMI) signature previously reported by INTERHEART‑Middle East. The authors identify rising obesity and diabetes in young men as the most urgent targets for regional primary prevention strategies, suggesting that interventions designed to reduce adiposity and prevent diabetes onset in younger male populations should be prioritized to address premature cardiovascular events.
The study relied exclusively on openly available NCD‑RisC modeled data; the authors report that all necessary ethical considerations were met given the public nature of the data source. Data are publicly available at ncdrisc.org. The source does not report primary data collection details, and limitations inherent to modeled prevalence estimates (for example, dependence on input data quality and modeling assumptions) apply; the authors performed sensitivity analyses but detailed limitations beyond those implied by data provenance were not reported in the source.
Using NCD‑RisC modeled prevalence estimates across 16 MENA countries, the analysis identified a sex‑asymmetric divergence in cardiometabolic risk trajectories from 1990 to the most recent available endpoints: worsening obesity and diabetes in young men, and improving hypertension and non‑HDL cholesterol in young women. These patterns align with prior observations of a young‑male AMI profile in the region and highlight obesity and diabetes prevention in young men as priority targets for regional cardiovascular prevention efforts.